EAM
EVH icon

Eventide Asset Management’s Evolent Health EVH Stock Holding History

Eventide Asset Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,547,558
Closed -$5.81M – 318
2026
Q1 		$5.81M Buy
+2,547,558
New +$8.08M 0.1% 157
2025
Q4 		– Sell
-6,292,511
Closed -$53.2M – 274
2025
Q3 		$53.2M Buy
6,292,511
+2,205,659
+54% +$21.4M 0.88% 36
2025
Q2 		$46M Sell
4,086,852
-1,990,339
-33% -$18.3M 0.81% 39
2025
Q1 		$57.6M Buy
6,077,191
+1,524,885
+33% +$15.4M 1.15% 24
2024
Q4 		$51.2M Buy
4,552,306
+748,202
+20% +$13.1M 0.93% 35
2024
Q3 		$108M Buy
3,804,104
+64,985
+2% +$1.67M 1.85% 11
2024
Q2 		$71.5M Buy
3,739,119
+1,096,551
+41% +$28M 1.22% 25
2024
Q1 		$86.6M Buy
2,642,568
+3,622
+0.1% +$116K 1.36% 19
2023
Q4 		$87.2M Buy
2,638,946
+6
+0% +$170 1.42% 22
2023
Q3 		$71.9M Buy
2,638,940
+796
+0% +$22.1K 1.29% 26
2023
Q2 		$79.9M Buy
2,638,144
+735,389
+39% +$23.8M 1.35% 22
2023
Q1 		$61.7M Hold
1,902,755
– – 1.13% 27
2022
Q4 		$53.4M Buy
1,902,755
+1,686,055
+778% +$48.3M 1.05% 33
2022
Q3 		$7.79M Hold
216,700
– – 0.15% 111
2022
Q2 		$6.66M Buy
+216,700
New +$6.31M 0.14% 110

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Eventide Asset Management's EVH Position: Q2 2026 in Review

Eventide Asset Management sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 2,547,558 shares — an estimated $5.81M sold.

Eventide Asset Management first reported a position in EVH in Q2 2022 and held it in 15 quarters. The position peaked at $108M in Q3 2024. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Eventide Asset Management reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • Eventide Asset Management sold 2,547,558 Evolent Health shares in Q2 2026, an estimated $5.81M.
  • Eventide Asset Management first reported a position in Evolent Health in Q2 2022 and held it in 15 quarters.
  • Eventide Asset Management's Evolent Health position peaked at $108M in Q3 2024.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.